Rapport Therapeutics Inc
rapportrx.comWhat Do They Do?
Develops small-molecule precision medicines for patients with neurological and psychiatric disorders, including epilepsy, bipolar disorder, and chronic pain.
10-K for FY2025, filed Mar 10, 2026We are a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients…View ↗
Our founders have made pioneering discoveries related to the function of RAPs in the brain. Their findings form the basis of our RAP…View ↗
We also have two advanced discovery-stage nicotinic acetylcholine receptor (“nAChR”) programs stemming from our RAP technology platform.…View ↗
How Do They Make Money?
No revenue reported yet.
10-K for FY2025, filed Mar 10, 2026
How Are They Changing?
Who Do They Compete With?
Competes with SK Life Science, UCB, Eisai, Xenon Pharmaceuticals, Biohaven, Praxis Precision Medicines, ES Therapeutics Australia, Supernus Pharmaceuticals, and Bristol Meyers Squibb
10-K for FY2025, filed Mar 10, 2026XCOPRI (cenobamate), which was developed by SK Life Science Inc. and approved by the FDA in November 2019; BRIVIACT (brivaracetam), which…View ↗
Loading...
